Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Harada

Showing results (241-250 of 261) with videos related to

Pageof 27
Sort By:
European Journal of Haematology|August 8, 2007
Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT groupYayoi Matsuo, Shoichiro Takeishi, Toshihiro Miyamoto, et al.
NPJ Science of Food|January 15, 2022
Identification of G protein-coupled receptor 55 (GPR55) as a target of curcuminNaoki Harada, Mai Okuyama, Yoshiaki Teraoka, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen ScanningToshihiro Aoki, Ikumi Hyohdoh, Noriyuki Furuichi, et al.
Cancer Research|May 14, 2013
Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activityNobuya Ishii, Naoki Harada, Eric W Joseph, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical PropertiesIkumi Hyohdoh, Noriyuki Furuichi, Toshihiro Aoki, et al.
Journal of Gastroenterology|May 9, 2014
The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
American Journal of Medical Genetics. Part A|August 8, 2006
Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown causeKiyonori Miura, Koh-Ichiro Yoshiura, Shoko Miura, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
FXR and BET signaling orchestrate to protect β cellsFritz Cayabyab, Jalan Tipirneni, David Chen, et al.
Journal of Gastroenterology|September 15, 2012
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelinesNaoki Harada, Naoki Hiramatsu, Tsugiko Oze, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
BAC array CGH reveals genomic aberrations in idiopathic mental retardationNoriko Miyake, Osamu Shimokawa, Naoki Harada, et al.
Pageof 27

Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
European Journal of Haematology|August 8, 2007
Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT groupYayoi Matsuo, Shoichiro Takeishi, Toshihiro Miyamoto, et al.
NPJ Science of Food|January 15, 2022
Identification of G protein-coupled receptor 55 (GPR55) as a target of curcuminNaoki Harada, Mai Okuyama, Yoshiaki Teraoka, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen ScanningToshihiro Aoki, Ikumi Hyohdoh, Noriyuki Furuichi, et al.
Cancer Research|May 14, 2013
Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activityNobuya Ishii, Naoki Harada, Eric W Joseph, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical PropertiesIkumi Hyohdoh, Noriyuki Furuichi, Toshihiro Aoki, et al.
Journal of Gastroenterology|May 9, 2014
The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
American Journal of Medical Genetics. Part A|August 8, 2006
Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown causeKiyonori Miura, Koh-Ichiro Yoshiura, Shoko Miura, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
FXR and BET signaling orchestrate to protect β cellsFritz Cayabyab, Jalan Tipirneni, David Chen, et al.
Journal of Gastroenterology|September 15, 2012
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelinesNaoki Harada, Naoki Hiramatsu, Tsugiko Oze, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
BAC array CGH reveals genomic aberrations in idiopathic mental retardationNoriko Miyake, Osamu Shimokawa, Naoki Harada, et al.
Pageof 27